# José Carlos Nicolau

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jose-carlos-nicolau/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,488 |
| Field | Acute Myocardial Infarction Research |
| h-index | 76 |
| i10-index | 264 |
| Last Known Institution | Hospital São Paulo |
| OpenAlex ID | https://openalex.org/A5000380712 |
| ORCID iD | 0000-0002-9680-3689 |
| Works | 680 |

## Researcher papers

Showing 12 of 18.

- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction](https://scholariq.org/papers/long-term-use-of-ticagrelor-in-patients-with-prior-myocardial-infarction/)
- [Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-interleukin-1-inhibition-with-canakinumab-on-incident-lung-cancer-in/)
- [Vorapaxar in the Secondary Prevention of Atherothrombotic Events](https://scholariq.org/papers/vorapaxar-in-the-secondary-prevention-of-atherothrombotic-events/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction](https://scholariq.org/papers/myocardial-viability-and-survival-in-ischemic-left-ventricular-dysfunction/)
- [Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization](https://scholariq.org/papers/prasugrel-versus-clopidogrel-for-acute-coronary-syndromes-without/)
- [Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease](https://scholariq.org/papers/evacetrapib-and-cardiovascular-outcomes-in-high-risk-vascular-disease/)
- [Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial](https://scholariq.org/papers/ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/)
- [Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.](https://scholariq.org/papers/therapeutic-anticoagulation-with-heparin-in-noncritically-ill-patients-with/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Salivary Gland Disorders and Functions](https://scholariq.org/topics/salivary-gland-disorders-and-functions/)

## Researcher university

- [Hospital São Paulo](https://scholariq.org/institutions/hospital-sao-paulo/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.